Riskpilot← Back to searchSign inGet full accessBartuma Eye Care AB
ABActiveOrg 5591738223Annedalsvägen 9 ABusiness and other management consultancy activities · NACE 7020Est. 201810-19 employees
Revenue 2024
SEK 2,2M
+1232% vs 2023
EBITDA margin
35.2%
+763% vs 2023
Equity ratio
11.7%
Financial strength
Net profit 2024
SEK 363K
+561% vs 2023
| Revenue | SEK 2,2M | +1232% |
| EBITDA | SEK 779K | +763% |
| Net profit | SEK 363K | +561% |
| Total assets | SEK 3,5M | +756% |
| Equity | SEK 414K | +294% |
| Employees | — | — |
Legal name
Bartuma Eye Care AB
Org number
5591738223
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
2 oktober 2018
Share capital
SEK 50 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Konsultverksamhet inom ögonsjukdomar samt utbildningsuppdrag och därmed förenlig verksamhet. Dessutom förvaltning av värdepapper. Förvärvning och försäljning av fastigheter
Address
Annedalsvägen 9 A
Email
katarina.bartuma@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 108 | 462 | 98 | 166 | 2 210 |
| Staff expenses | — | — | −21 | −14 | −83 |
| EBITDA | 104 | 443 | 44 | 90 | 779 |
| Depreciation & amort. | −0 | −0 | −16 | — | −132 |
| EBIT | 104 | 443 | 27 | 90 | 647 |
| Net financials | — | −1 | −0 | 5 | −43 |
| Profit before tax | 104 | 331 | 27 | 71 | 459 |
| Tax | −22 | −68 | −6 | −16 | −95 |
| Net profit | 82 | 263 | 21 | 55 | 363 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 488 | 952 | 870 | 414 | 3 545 |
| Equity | 373 | 636 | 657 | 105 | 414 |
| Long-term debt | 0 | 0 | — | — | 1 524 |
| Short-term debt | 115 | 205 | 103 | 173 | 1 326 |
| Total debt | 115 | 205 | 103 | 173 | 2 850 |
EBITDA margin
35.2%
This company
15.8%
Market median
+123% vs market
20202024
Equity ratio
11.7%
This company
38.2%
Market median
-69% vs market
20202024
Return on equity
87.9%
This company
18.4%
Market median
+378% vs market
20202024
Net profit margin
16.4%
This company
8.1%
Market median
+102% vs market
20202024
Asset turnover
0.62×
This company
1.12×
Market median
-45% vs market
20202024
Debt / equity
7.57×
This company
0.62×
Market median
-1121% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bartuma Eye Care AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Katarina Alicja Bartuma | Deputy Chief Executive Officer | 0 companies |
| Hammurabi Bartuma | Chairman | 0 companies |
| Kristoffer Ignacy Domanski | Deputy Board Member | 0 companies |